Research Analysts’ price target changes for Friday, August 7th:
Airbnb (NASDAQ:ABNB) had its price target increased by Cantor Fitzgerald from $140.00 to $160.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Airbnb (NASDAQ:ABNB) had its price target boosted by Oppenheimer Holdings, Inc. from $180.00 to $190.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Airbnb (NASDAQ:ABNB) had its target price raised by JPMorgan Chase & Co. from $140.00 to $170.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Airbnb (NASDAQ:ABNB) had its target price raised by Piper Sandler from $145.00 to $170.00. They currently have a neutral rating on the stock.
Abacus Global Management (NYSE:ABX) had its price target lowered by Piper Sandler from $13.00 to $12.00. They currently have a neutral rating on the stock.
Admiral Group (LON:ADM) had its target price boosted by Berenberg Bank from GBX 3,800 to GBX 4,200. They currently have a buy rating on the stock.
Admiral Group (LON:ADM) had its price target boosted by Citigroup Inc. from GBX 4,243 to GBX 4,516. Citigroup Inc. currently has a buy rating on the stock.
AGI (NYSE:AGBK) had its target price cut by Oppenheimer Holdings, Inc. from $10.00 to $9.00. The firm currently has an outperform rating on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) had its target price boosted by JPMorgan Chase & Co. from $31.00 to $34.00. They currently have a neutral rating on the stock.
American International Group (NYSE:AIG) had its target price boosted by Barclays PLC from $80.00 to $81.00. They currently have an equal weight rating on the stock.
Assurant (NYSE:AIZ) had its price target increased by Keefe, Bruyette & Woods from $310.00 to $325.00. The firm currently has an outperform rating on the stock.
Akamai Technologies (NASDAQ:AKAM) had its price target reduced by Piper Sandler from $156.00 to $140.00. Piper Sandler currently has a neutral rating on the stock.
Akamai Technologies (NASDAQ:AKAM) had its price target raised by Guggenheim from $181.00 to $190.00. Guggenheim currently has a buy rating on the stock.
Albemarle (NYSE:ALB) had its price target reduced by Truist Financial Corporation from $245.00 to $225.00. The firm currently has a buy rating on the stock.
Allegiant Travel (NASDAQ:ALGT) had its price target lowered by Susquehanna from $132.00 to $110.00. Susquehanna currently has a neutral rating on the stock.
Allient (NASDAQ:ALNT) had its target price raised by JPMorgan Chase & Co. from $95.00 to $120.00. The firm currently has an overweight rating on the stock.
Amphastar Pharmaceuticals (NASDAQ:AMPH) had its price target reduced by Piper Sandler from $21.00 to $20.00. They currently have a neutral rating on the stock.
Amphastar Pharmaceuticals (NASDAQ:AMPH) had its target price boosted by Wells Fargo & Company from $19.00 to $20.00. They currently have an equal weight rating on the stock.
Ardelyx (NASDAQ:ARDX) had its price target reduced by BTIG Research from $17.00 to $14.00. They currently have a buy rating on the stock.
Arhaus (NASDAQ:ARHS) had its target price increased by Piper Sandler from $8.00 to $9.00. The firm currently has a neutral rating on the stock.
Arhaus (NASDAQ:ARHS) had its target price increased by Telsey Advisory Group from $8.00 to $10.00. Telsey Advisory Group currently has a market perform rating on the stock.
Arlo Technologies (NYSE:ARLO) had its target price raised by Piper Sandler from $17.00 to $18.00. They currently have an overweight rating on the stock.
Arrow Electronics (NYSE:ARW) had its price target boosted by Wells Fargo & Company from $175.00 to $200.00. The firm currently has an underweight rating on the stock.
Arrow Electronics (NYSE:ARW) had its price target trimmed by Truist Financial Corporation from $260.00 to $250.00. They currently have a buy rating on the stock.
ATI (NYSE:ATI) had its target price increased by Susquehanna from $215.00 to $265.00. The firm currently has a positive rating on the stock.
ATI (NYSE:ATI) had its price target boosted by BTIG Research from $180.00 to $270.00. The firm currently has a buy rating on the stock.
Avient (NYSE:AVNT) had its price target increased by Truist Financial Corporation from $44.00 to $50.00. Truist Financial Corporation currently has a buy rating on the stock.
Avient (NYSE:AVNT) had its target price raised by Wells Fargo & Company from $47.00 to $48.00. Wells Fargo & Company currently has an overweight rating on the stock.
Avalo Therapeutics (NASDAQ:AVTX) had its target price cut by HC Wainwright from $35.00 to $30.00. The firm currently has a buy rating on the stock.
Atlanta Braves (NASDAQ:BATRK) had its target price trimmed by Rosenblatt Securities from $75.00 to $73.00. The firm currently has a buy rating on the stock.
Banco De Chile (NYSE:BCH) had its price target increased by JPMorgan Chase & Co. from $42.00 to $45.00. The firm currently has a neutral rating on the stock.
Becton, Dickinson and Company (NYSE:BDX) had its price target boosted by Piper Sandler from $161.00 to $175.00. The firm currently has a neutral rating on the stock.
Becton, Dickinson and Company (NYSE:BDX) had its price target boosted by Wells Fargo & Company from $161.00 to $170.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Blend Labs (NYSE:BLND) had its price target reduced by Wells Fargo & Company from $4.00 to $3.00. The firm currently has an overweight rating on the stock.
Blink Charging (NASDAQ:BLNK) had its target price trimmed by HC Wainwright to $2.50. HC Wainwright currently has a buy rating on the stock.
Bumble (NASDAQ:BMBL) had its price target cut by Susquehanna from $3.50 to $3.00. The firm currently has a neutral rating on the stock.
Bumble (NASDAQ:BMBL) had its target price trimmed by Wells Fargo & Company from $5.00 to $4.00. Wells Fargo & Company currently has an equal weight rating on the stock.
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target boosted by HC Wainwright from $50.00 to $60.00. The firm currently has a neutral rating on the stock.
BP (NYSE:BP) had its price target boosted by Piper Sandler from $42.00 to $43.00. They currently have a neutral rating on the stock.
Bentley Systems (NASDAQ:BSY) had its target price increased by BMO Capital Markets from $41.00 to $43.00. The firm currently has an outperform rating on the stock.
CACI International (NYSE:CACI) had its target price raised by JPMorgan Chase & Co. from $645.00 to $715.00. The firm currently has an overweight rating on the stock.
Maplebear (NASDAQ:CART) had its target price raised by JPMorgan Chase & Co. from $55.00 to $62.00. The firm currently has an overweight rating on the stock.
Maplebear (NASDAQ:CART) had its price target increased by Guggenheim from $44.00 to $46.00. They currently have a neutral rating on the stock.
Maplebear (NASDAQ:CART) had its target price increased by Benchmark Co. from $55.00 to $63.00. Benchmark Co. currently has a buy rating on the stock.
Maplebear (NASDAQ:CART) had its price target increased by Wells Fargo & Company from $47.00 to $54.00. The firm currently has an equal weight rating on the stock.
Maplebear (NASDAQ:CART) had its price target increased by Oppenheimer Holdings, Inc. from $60.00 to $65.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Maplebear (NASDAQ:CART) had its target price boosted by Needham & Company LLC from $55.00 to $63.00. The firm currently has a buy rating on the stock.
Maplebear (NASDAQ:CART) had its target price increased by Cantor Fitzgerald from $56.00 to $63.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Cabot (NYSE:CBT) had its target price increased by JPMorgan Chase & Co. from $70.00 to $78.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Cogent Communications (NASDAQ:CCOI) had its price target cut by KeyCorp from $25.00 to $15.00. KeyCorp currently has an overweight rating on the stock.
Cogent Communications (NASDAQ:CCOI) had its target price lowered by Wells Fargo & Company from $18.00 to $14.00. They currently have an equal weight rating on the stock.
Cadre (NYSE:CDRE) had its target price raised by JPMorgan Chase & Co. from $40.00 to $45.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Celsius (NASDAQ:CELH) had its target price cut by Piper Sandler from $49.00 to $36.00. They currently have an overweight rating on the stock.
Cognex (NASDAQ:CGNX) had its price target increased by Needham & Company LLC from $75.00 to $80.00. They currently have a buy rating on the stock.
Cognex (NASDAQ:CGNX) had its price target boosted by Cantor Fitzgerald from $76.00 to $84.00. The firm currently has an overweight rating on the stock.
Cognex (NASDAQ:CGNX) had its target price raised by Truist Financial Corporation from $71.00 to $78.00. The firm currently has a hold rating on the stock.
CG Oncology (NASDAQ:CGON) had its target price increased by Truist Financial Corporation from $82.00 to $85.00. The firm currently has a buy rating on the stock.
CG Oncology (NASDAQ:CGON) had its target price raised by Piper Sandler from $82.00 to $85.00. They currently have an overweight rating on the stock.
Chime Financial (NASDAQ:CHYM) had its target price raised by Barclays PLC from $26.00 to $33.00. They currently have an overweight rating on the stock.
Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by Barclays PLC from $48.00 to $53.00. Barclays PLC currently has an overweight rating on the stock.
Climb Bio (NASDAQ:CLYM) had its target price boosted by Truist Financial Corporation from $17.00 to $25.00. They currently have a buy rating on the stock.
Compass Therapeutics (NASDAQ:CMPX) had its price target increased by Piper Sandler from $4.00 to $6.00. Piper Sandler currently has an overweight rating on the stock.
Cencora (NYSE:COR) had its target price increased by JPMorgan Chase & Co. from $382.00 to $390.00. The firm currently has an overweight rating on the stock.
Corbus Pharmaceuticals (NASDAQ:CRBP) had its target price reduced by Oppenheimer Holdings, Inc. from $52.00 to $48.00. They currently have an outperform rating on the stock.
Corbus Pharmaceuticals (NASDAQ:CRBP) had its target price trimmed by HC Wainwright from $40.00 to $35.00. HC Wainwright currently has a buy rating on the stock.
CryoPort (NASDAQ:CYRX) had its price target increased by Needham & Company LLC from $15.00 to $19.00. The firm currently has a buy rating on the stock.
Cytokinetics (NASDAQ:CYTK) had its price target raised by Needham & Company LLC from $102.00 to $112.00. The firm currently has a buy rating on the stock.
Cytokinetics (NASDAQ:CYTK) had its target price increased by Citizens Jmp from $105.00 to $110.00. They currently have a market outperform rating on the stock.
Dana (NYSE:DAN) had its target price lowered by Wells Fargo & Company from $33.00 to $28.00. They currently have an equal weight rating on the stock.
Douglas Emmett (NYSE:DEI) had its target price increased by Cantor Fitzgerald from $12.00 to $13.00. The firm currently has a neutral rating on the stock.
DNOW (NYSE:DNOW) had its price target increased by Susquehanna from $16.00 to $19.00. They currently have a positive rating on the stock.
Doximity (NYSE:DOCS) had its price target increased by JPMorgan Chase & Co. from $26.00 to $31.00. The firm currently has a neutral rating on the stock.
DoubleVerify (NYSE:DV) was given a $13.60 target price by analysts at Wells Fargo & Company. The firm currently has an equal weight rating on the stock.
DaVita (NYSE:DVA) had its target price lowered by Truist Financial Corporation from $250.00 to $215.00. The firm currently has a hold rating on the stock.
Consolidated Edison (NYSE:ED) had its price target raised by Wells Fargo & Company from $106.00 to $108.00. They currently have an equal weight rating on the stock.
Encompass Health (NYSE:EHC) had its target price boosted by Truist Financial Corporation from $140.00 to $150.00. The firm currently has a buy rating on the stock.
Enovis (NYSE:ENOV) had its target price cut by Wells Fargo & Company from $40.00 to $39.00. They currently have an overweight rating on the stock.
EPAM Systems (NYSE:EPAM) had its price target trimmed by Truist Financial Corporation from $112.00 to $110.00. They currently have a hold rating on the stock.
EPAM Systems (NYSE:EPAM) had its target price trimmed by Susquehanna from $167.00 to $146.00. Susquehanna currently has a positive rating on the stock.
Establishment Labs (NASDAQ:ESTA) had its target price raised by JPMorgan Chase & Co. from $84.00 to $95.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Etsy (NYSE:ETSY) had its price target boosted by Piper Sandler from $70.00 to $80.00. Piper Sandler currently has a neutral rating on the stock.
Etsy (NYSE:ETSY) had its price target increased by Wells Fargo & Company from $61.00 to $76.00. They currently have an underweight rating on the stock.
Etsy (NYSE:ETSY) had its price target boosted by Needham & Company LLC from $85.00 to $100.00. The firm currently has a buy rating on the stock.
Etsy (NYSE:ETSY) had its target price increased by Cantor Fitzgerald from $80.00 to $85.00. The firm currently has a neutral rating on the stock.
Expedia Group (NASDAQ:EXPE) had its target price boosted by Wells Fargo & Company from $303.00 to $307.00. The firm currently has an equal weight rating on the stock.
easyJet (LON:EZJ) had its target price increased by JPMorgan Chase & Co. from GBX 360 to GBX 715. They currently have a neutral rating on the stock.
FIGS (NYSE:FIGS) had its price target raised by BTIG Research from $20.00 to $22.00. The firm currently has a buy rating on the stock.
FIGS (NYSE:FIGS) had its target price trimmed by Telsey Advisory Group from $17.00 to $16.00. Telsey Advisory Group currently has a market perform rating on the stock.
Fiserv (NASDAQ:FISV) had its price target reduced by Susquehanna from $91.00 to $85.00. They currently have a positive rating on the stock.
Fiserv (NASDAQ:FISV) had its target price trimmed by Keefe, Bruyette & Woods from $70.00 to $65.00. The firm currently has an outperform rating on the stock.
Five9 (NASDAQ:FIVN) had its target price boosted by Rosenblatt Securities from $29.00 to $32.00. They currently have a buy rating on the stock.
Five9 (NASDAQ:FIVN) had its price target increased by Truist Financial Corporation from $23.00 to $35.00. They currently have a buy rating on the stock.
Five9 (NASDAQ:FIVN) had its target price raised by Piper Sandler from $24.00 to $30.00. Piper Sandler currently has a neutral rating on the stock.
Full House Resorts (NASDAQ:FLL) had its price target lowered by Citizens Jmp from $4.00 to $3.00. Citizens Jmp currently has a market outperform rating on the stock.
Fidelity National Financial (NYSE:FNF) had its price target boosted by Barclays PLC from $51.00 to $54.00. Barclays PLC currently has an equal weight rating on the stock.
JFrog (NASDAQ:FROG) had its price target boosted by BTIG Research from $100.00 to $115.00. They currently have a buy rating on the stock.
JFrog (NASDAQ:FROG) had its target price increased by Truist Financial Corporation from $105.00 to $110.00. Truist Financial Corporation currently has a buy rating on the stock.
JFrog (NASDAQ:FROG) had its target price increased by Oppenheimer Holdings, Inc. from $105.00 to $115.00. They currently have an outperform rating on the stock.
JFrog (NASDAQ:FROG) had its price target raised by Piper Sandler from $65.00 to $90.00. The firm currently has a neutral rating on the stock.
JFrog (NASDAQ:FROG) had its target price increased by JPMorgan Chase & Co. from $100.00 to $115.00. They currently have an overweight rating on the stock.
FS KKR Capital (NYSE:FSK) had its price target raised by Truist Financial Corporation from $11.00 to $12.00. Truist Financial Corporation currently has a hold rating on the stock.
First Solar (NASDAQ:FSLR) had its target price increased by Wells Fargo & Company from $300.00 to $313.00. Wells Fargo & Company currently has an overweight rating on the stock.
Frontdoor (NASDAQ:FTDR) had its target price boosted by Truist Financial Corporation from $82.00 to $105.00. The firm currently has a buy rating on the stock.
Six Flags Entertainment (NYSE:FUN) had its price target reduced by Citizens Jmp from $29.00 to $24.00. They currently have a market outperform rating on the stock.
Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) had its price target increased by Wells Fargo & Company from $97.00 to $105.00. They currently have an equal weight rating on the stock.
Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) had its price target increased by JPMorgan Chase & Co. from $124.00 to $125.00. They currently have an overweight rating on the stock.
First Watch Restaurant Group (NASDAQ:FWRG) had its price target cut by Guggenheim from $21.00 to $20.00. They currently have a buy rating on the stock.
Genpact (NYSE:G) had its price target boosted by JPMorgan Chase & Co. from $40.00 to $45.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Genpact (NYSE:G) had its target price raised by Susquehanna from $33.00 to $37.00. They currently have a neutral rating on the stock.
Genpact (NYSE:G) had its target price cut by Needham & Company LLC from $50.00 to $45.00. They currently have a buy rating on the stock.
GoodRx (NASDAQ:GDRX) had its price target increased by Wells Fargo & Company from $3.50 to $5.00. Wells Fargo & Company currently has an overweight rating on the stock.
Gen Digital (NASDAQ:GEN) had its target price raised by Wells Fargo & Company from $22.00 to $28.00. They currently have an equal weight rating on the stock.
Genius Sports (NYSE:GENI) had its price target raised by Oppenheimer Holdings, Inc. from $10.00 to $12.00. They currently have an outperform rating on the stock.
GH Research (NASDAQ:GHRS) had its target price increased by Cantor Fitzgerald from $35.00 to $40.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Glencore (LON:GLEN) had its target price cut by Berenberg Bank from GBX 750 to GBX 740. The firm currently has a buy rating on the stock.
Monte Rosa Therapeutics (NASDAQ:GLUE) had its price target trimmed by Wells Fargo & Company from $29.00 to $27.00. Wells Fargo & Company currently has an overweight rating on the stock.
Genmab A/S (NASDAQ:GMAB) had its price target boosted by Guggenheim from $40.00 to $42.00. The firm currently has a buy rating on the stock.
Globus Medical (NYSE:GMED) had its target price cut by Wells Fargo & Company from $103.00 to $99.00. Wells Fargo & Company currently has an overweight rating on the stock.
Structure Therapeutics (NASDAQ:GPCR) had its price target lowered by Citizens Jmp from $113.00 to $110.00. The firm currently has a market outperform rating on the stock.
Goodyear Tire & Rubber (NASDAQ:GT) had its target price raised by JPMorgan Chase & Co. from $9.00 to $10.00. The firm currently has an overweight rating on the stock.
Haemonetics (NYSE:HAE) had its price target increased by JPMorgan Chase & Co. from $62.00 to $86.00. They currently have a neutral rating on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its target price boosted by Citizens Jmp from $92.00 to $93.00. Citizens Jmp currently has a market outperform rating on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its price target increased by HC Wainwright from $95.00 to $115.00. They currently have a buy rating on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its price target raised by Wells Fargo & Company from $75.00 to $95.00. Wells Fargo & Company currently has an equal weight rating on the stock.
HA Sustainable Infrastructure Capital (NYSE:HASI) had its price target boosted by JPMorgan Chase & Co. from $50.00 to $51.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
HCI Group (NYSE:HCI) had its price target boosted by Citizens Jmp from $255.00 to $265.00. The firm currently has a market outperform rating on the stock.
Hamilton Insurance Group (NYSE:HG) had its price target boosted by Citizens Jmp from $40.00 to $42.00. The firm currently has a market outperform rating on the stock.
Hagerty (NYSE:HGTY) had its target price increased by Truist Financial Corporation from $11.00 to $13.00. Truist Financial Corporation currently has a hold rating on the stock.
Helmerich & Payne (NYSE:HP) had its price target increased by Susquehanna from $40.00 to $44.00. The firm currently has a positive rating on the stock.
Hudson Pacific Properties (NYSE:HPP) had its price target boosted by Cantor Fitzgerald from $14.00 to $17.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Horizon Technology Finance (NASDAQ:HRZN) had its target price trimmed by Oppenheimer Holdings, Inc. from $6.00 to $5.00. They currently have a market perform rating on the stock.
HSBC (LON:HSBA) had its price target increased by JPMorgan Chase & Co. from GBX 1,380 to GBX 1,450. The firm currently has a neutral rating on the stock.
Hiscox (LON:HSX) had its target price boosted by Berenberg Bank from GBX 1,900 to GBX 2,150. They currently have a buy rating on the stock.
Howmet Aerospace (NYSE:HWM) had its price target increased by Susquehanna from $330.00 to $340.00. Susquehanna currently has a positive rating on the stock.
ICU Medical (NASDAQ:ICUI) had its target price increased by Needham & Company LLC from $165.00 to $187.00. Needham & Company LLC currently has a buy rating on the stock.
ICU Medical (NASDAQ:ICUI) had its target price raised by Piper Sandler from $163.00 to $195.00. They currently have an overweight rating on the stock.
InflaRx (NASDAQ:IFRX) had its target price increased by Cantor Fitzgerald from $4.00 to $6.00. They currently have an overweight rating on the stock.
Innoviva (NASDAQ:INVA) had its target price reduced by Cantor Fitzgerald from $36.00 to $34.00. They currently have an overweight rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its target price raised by Citizens Jmp from $5.00 to $8.00. They currently have a market outperform rating on the stock.
iRhythm Technologies (NASDAQ:IRTC) had its price target cut by Wells Fargo & Company from $180.00 to $168.00. The firm currently has an overweight rating on the stock.
James Hardie Industries (NYSE:JHX) had its price target raised by Stephens from $33.00 to $34.00. The firm currently has an overweight rating on the stock.
James Hardie Industries (NYSE:JHX) had its price target boosted by Truist Financial Corporation from $30.00 to $40.00. They currently have a buy rating on the stock.
Karman (NYSE:KRMN) had its price target cut by Needham & Company LLC from $125.00 to $80.00. The firm currently has a buy rating on the stock.
Lamar Advertising (NASDAQ:LAMR) had its price target raised by JPMorgan Chase & Co. from $153.00 to $160.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Centrus Energy (NYSE:LEU) had its target price boosted by JPMorgan Chase & Co. from $178.00 to $180.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Centrus Energy (NYSE:LEU) had its target price trimmed by Needham & Company LLC from $264.00 to $262.00. The firm currently has a buy rating on the stock.
LifeMD (NASDAQ:LFMD) had its price target lowered by HC Wainwright from $10.00 to $9.00. HC Wainwright currently has a buy rating on the stock.
LifeStance Health Group (NASDAQ:LFST) had its target price boosted by BTIG Research from $15.00 to $16.00. BTIG Research currently has a buy rating on the stock.
Eli Lilly and Company (NYSE:LLY) had its target price increased by Truist Financial Corporation from $1,370.00 to $1,376.00. The firm currently has a buy rating on the stock.
London Stock Exchange Group (LON:LSEG) had its target price lowered by Citigroup Inc. from £129 to £127. The firm currently has a buy rating on the stock.
Lyft (NASDAQ:LYFT) had its price target increased by Cantor Fitzgerald from $14.00 to $17.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Lyft (NASDAQ:LYFT) had its target price increased by JPMorgan Chase & Co. from $18.00 to $19.00. The firm currently has a neutral rating on the stock.
Marathon Digital (NASDAQ:MARA) had its price target trimmed by Cantor Fitzgerald from $14.00 to $12.00. They currently have an overweight rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its target price lowered by Truist Financial Corporation from $105.00 to $90.00. The firm currently has a hold rating on the stock.
MidCap Financial Investment (NASDAQ:MFIC) had its price target trimmed by Truist Financial Corporation from $13.00 to $12.00. Truist Financial Corporation currently has a buy rating on the stock.
Magnite (NASDAQ:MGNI) had its target price increased by Wells Fargo & Company from $21.00 to $22.00. The firm currently has an equal weight rating on the stock.
Miami International (NYSE:MIAX) had its target price raised by Keefe, Bruyette & Woods from $46.00 to $48.00. They currently have a market perform rating on the stock.
MKS (NASDAQ:MKSI) had its price target boosted by Wells Fargo & Company from $300.00 to $325.00. Wells Fargo & Company currently has an equal weight rating on the stock.
MKS (NASDAQ:MKSI) had its target price increased by JPMorgan Chase & Co. from $365.00 to $380.00. The firm currently has an overweight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target boosted by Piper Sandler from $94.00 to $101.00. They currently have an overweight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target increased by UBS Group AG from $104.00 to $105.00. They currently have a neutral rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target boosted by Evercore Inc from $95.00 to $105.00. Evercore Inc currently has an outperform rating on the stock.
Maravai LifeSciences (NASDAQ:MRVI) had its price target raised by Wells Fargo & Company from $5.50 to $6.50. The firm currently has an overweight rating on the stock.
Motorola Solutions (NYSE:MSI) had its target price boosted by Truist Financial Corporation from $525.00 to $545.00. They currently have a buy rating on the stock.
Cloudflare (NYSE:NET) had its price target raised by Truist Financial Corporation from $300.00 to $350.00. The firm currently has a buy rating on the stock.
Cloudflare (NYSE:NET) had its price target raised by BTIG Research from $314.00 to $382.00. They currently have a buy rating on the stock.
Cloudflare (NYSE:NET) had its price target boosted by Oppenheimer Holdings, Inc. from $330.00 to $380.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Cloudflare (NYSE:NET) had its price target increased by Needham & Company LLC from $280.00 to $380.00. Needham & Company LLC currently has a buy rating on the stock.
Cloudflare (NYSE:NET) had its price target raised by Citizens Jmp from $330.00 to $394.00. The firm currently has a market outperform rating on the stock.
Cloudflare (NYSE:NET) had its price target increased by Piper Sandler from $250.00 to $333.00. They currently have an overweight rating on the stock.
NewtekOne (NASDAQ:NEWT) had its price target raised by Piper Sandler from $14.00 to $15.00. Piper Sandler currently has a neutral rating on the stock.
NexPoint Real Estate Finance (NYSE:NREF) had its price target increased by Piper Sandler from $16.00 to $17.50. Piper Sandler currently has a neutral rating on the stock.
Insight Enterprises (NASDAQ:NSIT) had its price target boosted by JPMorgan Chase & Co. from $135.00 to $160.00. The firm currently has a neutral rating on the stock.
Natera (NASDAQ:NTRA) had its target price raised by JPMorgan Chase & Co. from $315.00 to $360.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Nova (NASDAQ:NVMI) had its price target trimmed by Needham & Company LLC from $640.00 to $570.00. They currently have a buy rating on the stock.
Nova (NASDAQ:NVMI) had its price target lowered by Cantor Fitzgerald from $600.00 to $500.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Nexstar Media Group (NASDAQ:NXST) had its price target trimmed by Wells Fargo & Company from $253.00 to $249.00. The firm currently has an overweight rating on the stock.
Odyssey Therapeutics (NASDAQ:ODTX) had its target price raised by JPMorgan Chase & Co. from $26.00 to $29.00. The firm currently has an overweight rating on the stock.
Once Upon A Farm (NYSE:OFRM) had its target price raised by JPMorgan Chase & Co. from $22.00 to $26.00. They currently have an overweight rating on the stock.
Onto Innovation (NYSE:ONTO) had its price target boosted by Needham & Company LLC from $330.00 to $360.00. The firm currently has a buy rating on the stock.
Ormat Technologies (NYSE:ORA) had its price target reduced by Oppenheimer Holdings, Inc. from $144.00 to $141.00. The firm currently has an outperform rating on the stock.
Organogenesis (NASDAQ:ORGO) had its price target cut by Truist Financial Corporation from $3.00 to $2.00. They currently have a hold rating on the stock.
Blue Owl Technology Finance (NYSE:OTF) had its price target boosted by Citizens Jmp from $16.00 to $17.00. The firm currently has a market outperform rating on the stock.
Occidental Petroleum (NYSE:OXY) had its price target boosted by Wells Fargo & Company from $72.00 to $79.00. The firm currently has an overweight rating on the stock.
PAR Technology (NYSE:PAR) had its target price boosted by JPMorgan Chase & Co. from $17.00 to $18.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Par Pacific (NYSE:PARR) had its target price lowered by TD Cowen from $100.00 to $95.00. TD Cowen currently has a buy rating on the stock.
PureCycle Technologies (NASDAQ:PCT) had its price target trimmed by Cantor Fitzgerald from $14.00 to $12.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Parker-Hannifin (NYSE:PH) had its price target raised by Susquehanna from $1,100.00 to $1,250.00. The firm currently has a positive rating on the stock.
Parker-Hannifin (NYSE:PH) had its price target boosted by Truist Financial Corporation from $1,269.00 to $1,358.00. The firm currently has a buy rating on the stock.
Priority Technology (NASDAQ:PRTH) had its price target trimmed by Keefe, Bruyette & Woods from $7.50 to $6.50. They currently have a market perform rating on the stock.
PubMatic (NASDAQ:PUBM) had its price target increased by Rosenblatt Securities from $21.00 to $23.00. Rosenblatt Securities currently has a buy rating on the stock.
PubMatic (NASDAQ:PUBM) had its price target raised by Citizens Jmp from $12.00 to $20.00. The firm currently has a market outperform rating on the stock.
Papa John’s International (NASDAQ:PZZA) had its price target trimmed by Piper Sandler from $30.00 to $26.00. They currently have a neutral rating on the stock.
Qiagen (NYSE:QGEN) had its price target increased by JPMorgan Chase & Co. from $45.00 to $50.00. The firm currently has an overweight rating on the stock.
Quilter (LON:QLT) had its price target increased by Berenberg Bank from GBX 215 to GBX 220. The firm currently has a buy rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its price target reduced by Piper Sandler from $85.00 to $81.00. They currently have an overweight rating on the stock.
Red Cat (NASDAQ:RCAT) had its target price reduced by Needham & Company LLC from $20.00 to $15.00. They currently have a buy rating on the stock.
Replimune Group (NASDAQ:REPL) had its target price boosted by JPMorgan Chase & Co. from $17.00 to $20.00. The firm currently has an overweight rating on the stock.
Rocket Companies (NYSE:RKT) had its price target cut by Stephens from $22.50 to $20.00. They currently have an overweight rating on the stock.
Rocket Companies (NYSE:RKT) had its price target trimmed by Wells Fargo & Company from $17.00 to $15.00. They currently have an equal weight rating on the stock.
Ralph Lauren (NYSE:RL) had its target price increased by Telsey Advisory Group from $460.00 to $470.00. The firm currently has an outperform rating on the stock.
ResMed (NYSE:RMD) had its price target reduced by Wells Fargo & Company from $225.00 to $215.00. The firm currently has an equal weight rating on the stock.
ResMed (NYSE:RMD) had its price target cut by Piper Sandler from $233.00 to $225.00. The firm currently has a neutral rating on the stock.
Roivant Sciences (NASDAQ:ROIV) had its price target boosted by Guggenheim from $36.00 to $42.00. Guggenheim currently has a buy rating on the stock.
Royalty Pharma (NASDAQ:RPRX) had its target price boosted by JPMorgan Chase & Co. from $58.00 to $62.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Sunrun (NASDAQ:RUN) had its price target reduced by Susquehanna from $18.00 to $15.00. They currently have a positive rating on the stock.
RXO (NYSE:RXO) had its target price reduced by Truist Financial Corporation from $30.00 to $28.00. They currently have a buy rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target boosted by JPMorgan Chase & Co. from $145.00 to $146.00. The firm currently has an overweight rating on the stock.
J Sainsbury (LON:SBRY) had its target price boosted by Citigroup Inc. from GBX 330 to GBX 346. Citigroup Inc. currently has a neutral rating on the stock.
Solaris Energy Infrastructure (NYSE:SEI) had its price target boosted by Needham & Company LLC from $97.00 to $98.00. They currently have a buy rating on the stock.
Sezzle (NASDAQ:SEZL) had its target price trimmed by Keefe, Bruyette & Woods from $190.00 to $155.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Sezzle (NASDAQ:SEZL) had its target price raised by Needham & Company LLC from $166.00 to $172.00. They currently have a buy rating on the stock.
Sweetgreen (NYSE:SG) had its target price trimmed by TD Cowen from $8.00 to $5.00. The firm currently has a hold rating on the stock.
Sweetgreen (NYSE:SG) had its price target lowered by Wells Fargo & Company from $7.00 to $6.00. The firm currently has an equal weight rating on the stock.
Sweetgreen (NYSE:SG) had its target price trimmed by Oppenheimer Holdings, Inc. from $10.00 to $8.50. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Somnigroup International (NYSE:SGI) had its price target lowered by Truist Financial Corporation from $115.00 to $100.00. Truist Financial Corporation currently has a buy rating on the stock.
SharonAI Holdings, Inc. Class A Common Stock (NASDAQ:SHAZ) had its price target reduced by Cantor Fitzgerald from $116.00 to $109.00. The firm currently has an overweight rating on the stock.
Sotera Health (NASDAQ:SHC) had its price target boosted by JPMorgan Chase & Co. from $16.00 to $18.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Shoulder Innovations (NYSE:SI) had its price target increased by BTIG Research from $24.00 to $26.00. The firm currently has a buy rating on the stock.
Serco Group (LON:SRP) had its price target boosted by Citigroup Inc. from GBX 371 to GBX 372. They currently have a buy rating on the stock.
St. James’s Place (LON:STJ) had its target price raised by Berenberg Bank from GBX 1,800 to GBX 1,945. The firm currently has a buy rating on the stock.
Starwood Property Trust (NYSE:STWD) had its price target lowered by Keefe, Bruyette & Woods from $19.00 to $18.50. They currently have an outperform rating on the stock.
Sui Group (NASDAQ:SUIG) had its target price cut by Cantor Fitzgerald from $1.90 to $1.70. The firm currently has an overweight rating on the stock.
Savers Value Village (NYSE:SVV) had its price target increased by JPMorgan Chase & Co. from $11.00 to $14.00. They currently have a neutral rating on the stock.
Savers Value Village (NYSE:SVV) had its price target raised by Piper Sandler from $10.00 to $11.00. The firm currently has a neutral rating on the stock.
Southwest Gas (NYSE:SWX) had its target price boosted by Wells Fargo & Company from $105.00 to $107.00. The firm currently has an overweight rating on the stock.
Synaptics (NASDAQ:SYNA) had its price target cut by Wells Fargo & Company from $160.00 to $140.00. Wells Fargo & Company currently has an overweight rating on the stock.
Synaptics (NASDAQ:SYNA) had its price target lowered by Rosenblatt Securities from $160.00 to $115.00. They currently have a neutral rating on the stock.
Synthomer (LON:SYNT) had its target price boosted by Berenberg Bank from GBX 100 to GBX 110. The firm currently has a hold rating on the stock.
Molson Coors Beverage (NYSE:TAP) had its price target cut by Piper Sandler from $45.00 to $44.00. They currently have a neutral rating on the stock.
Atlassian (NASDAQ:TEAM) had its price target raised by Oppenheimer Holdings, Inc. from $110.00 to $200.00. They currently have an outperform rating on the stock.
Atlassian (NASDAQ:TEAM) had its target price boosted by Truist Financial Corporation from $100.00 to $160.00. The firm currently has a buy rating on the stock.
Atlassian (NASDAQ:TEAM) had its target price raised by BMO Capital Markets from $95.00 to $175.00. BMO Capital Markets currently has an outperform rating on the stock.
Tectonic Therapeutic (NASDAQ:TECX) had its price target reduced by Wells Fargo & Company from $101.00 to $93.00. Wells Fargo & Company currently has an overweight rating on the stock.
Target (NYSE:TGT) had its price target increased by JPMorgan Chase & Co. from $129.00 to $157.00. The firm currently has a neutral rating on the stock.
TG Therapeutics (NASDAQ:TGTX) had its price target raised by JPMorgan Chase & Co. from $65.00 to $72.00. The firm currently has an overweight rating on the stock.
Travis Perkins (LON:TPK) had its target price increased by JPMorgan Chase & Co. from GBX 630 to GBX 710. They currently have an overweight rating on the stock.
Targa Resources (NYSE:TRGP) had its target price increased by TD Cowen from $270.00 to $275.00. TD Cowen currently has a hold rating on the stock.
Targa Resources (NYSE:TRGP) had its price target raised by Wells Fargo & Company from $270.00 to $282.00. They currently have an overweight rating on the stock.
TripAdvisor (NASDAQ:TRIP) had its price target cut by Cantor Fitzgerald from $10.00 to $9.00. Cantor Fitzgerald currently has an underweight rating on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its price target increased by Cantor Fitzgerald from $25.00 to $30.00. The firm currently has an overweight rating on the stock.
Trade Desk (NASDAQ:TTD) had its price target trimmed by Rosenblatt Securities from $24.00 to $12.00. Rosenblatt Securities currently has a neutral rating on the stock.
Trade Desk (NASDAQ:TTD) had its target price reduced by Cantor Fitzgerald from $20.00 to $14.00. The firm currently has a neutral rating on the stock.
Trade Desk (NASDAQ:TTD) had its target price cut by Needham & Company LLC from $25.00 to $19.00. Needham & Company LLC currently has a buy rating on the stock.
TechTarget (NASDAQ:TTGT) had its target price cut by Needham & Company LLC from $15.00 to $8.00. Needham & Company LLC currently has a buy rating on the stock.
Twilio (NYSE:TWLO) had its price target raised by Rosenblatt Securities from $230.00 to $275.00. They currently have a buy rating on the stock.
Twilio (NYSE:TWLO) had its target price boosted by Needham & Company LLC from $250.00 to $280.00. Needham & Company LLC currently has a buy rating on the stock.
Twilio (NYSE:TWLO) had its price target raised by BTIG Research from $245.00 to $285.00. BTIG Research currently has a buy rating on the stock.
Twilio (NYSE:TWLO) had its target price increased by Monness Crespi & Hardt from $246.00 to $270.00. They currently have a buy rating on the stock.
Twilio (NYSE:TWLO) had its target price increased by Citizens Jmp from $250.00 to $275.00. They currently have a market outperform rating on the stock.
Twilio (NYSE:TWLO) had its target price raised by Oppenheimer Holdings, Inc. from $235.00 to $275.00. They currently have an outperform rating on the stock.
Twilio (NYSE:TWLO) had its target price raised by Piper Sandler from $192.00 to $247.00. Piper Sandler currently has a neutral rating on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its price target raised by Stephens from $180.00 to $205.00. They currently have an equal weight rating on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its target price increased by BTIG Research from $200.00 to $220.00. They currently have a buy rating on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its price target boosted by TD Cowen from $205.00 to $230.00. The firm currently has a buy rating on the stock.
Unity Software (NYSE:U) had its price target raised by Oppenheimer Holdings, Inc. from $38.00 to $47.00. The firm currently has an outperform rating on the stock.
Unity Software (NYSE:U) had its target price raised by Citizens Jmp from $37.00 to $45.00. The firm currently has a market outperform rating on the stock.
Unity Software (NYSE:U) had its price target raised by Needham & Company LLC from $40.00 to $54.00. The firm currently has a buy rating on the stock.
Unity Software (NYSE:U) had its price target increased by Wells Fargo & Company from $36.00 to $48.00. They currently have an overweight rating on the stock.
UGI (NYSE:UGI) had its price target reduced by Wells Fargo & Company from $45.00 to $42.00. They currently have an overweight rating on the stock.
US Foods (NYSE:USFD) had its price target increased by BTIG Research from $105.00 to $120.00. They currently have a buy rating on the stock.
US Foods (NYSE:USFD) had its target price increased by Wells Fargo & Company from $110.00 to $125.00. The firm currently has an overweight rating on the stock.
Marriott Vacations Worldwide (NYSE:VAC) had its target price raised by Wells Fargo & Company from $68.00 to $101.00. They currently have an underweight rating on the stock.
Valaris (NYSE:VAL) had its target price raised by Susquehanna from $75.00 to $80.00. Susquehanna currently has a neutral rating on the stock.
Victory Capital (NASDAQ:VCTR) had its price target increased by JPMorgan Chase & Co. from $87.00 to $101.00. The firm currently has a neutral rating on the stock.
Via Transportation (NYSE:VIA) had its price target boosted by Wells Fargo & Company from $30.00 to $32.00. Wells Fargo & Company currently has an overweight rating on the stock.
Vital Farms (NASDAQ:VITL) had its target price raised by Needham & Company LLC from $13.00 to $14.00. Needham & Company LLC currently has a buy rating on the stock.
Viridian Therapeutics (NASDAQ:VRDN) had its price target raised by Truist Financial Corporation from $38.00 to $39.00. They currently have a buy rating on the stock.
Walker & Dunlop (NYSE:WD) had its target price trimmed by Keefe, Bruyette & Woods from $63.00 to $57.00. The firm currently has an outperform rating on the stock.
Wizz Air (LON:WIZZ) had its target price reduced by Citigroup Inc. from GBX 1,200 to GBX 1,150. They currently have a neutral rating on the stock.
WPP (LON:WPP) had its target price increased by JPMorgan Chase & Co. from GBX 350 to GBX 390. The firm currently has a neutral rating on the stock.
Warby Parker (NYSE:WRBY) had its target price trimmed by Citizens Jmp from $30.00 to $29.00. They currently have a market outperform rating on the stock.
Block (NYSE:XYZ) had its price target boosted by Monness Crespi & Hardt from $115.00 to $125.00. They currently have a buy rating on the stock.
Zillow Group (NASDAQ:Z) had its price target lowered by Keefe, Bruyette & Woods from $37.00 to $34.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Zillow Group (NASDAQ:ZG) had its target price reduced by Citizens Jmp from $75.00 to $46.00. They currently have a market outperform rating on the stock.
Zillow Group (NASDAQ:ZG) had its target price reduced by Wells Fargo & Company from $46.00 to $35.00. The firm currently has an equal weight rating on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its target price lowered by Guggenheim from $24.00 to $23.00. Guggenheim currently has a buy rating on the stock.
Zymeworks (NASDAQ:ZYME) had its price target raised by Truist Financial Corporation from $31.00 to $32.00. They currently have a buy rating on the stock.
Receive News & Ratings for Airbnb Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Airbnb Inc and related companies with MarketBeat.com's FREE daily email newsletter.
